SM
NMTR

Sabby Management’s 9 Meters Biopharma NMTR Stock Holding History

Sabby Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6
Closed -$50K – 153
2022
Q1 		$50K Sell
6
-154
-96% -$2.1K 0.01% 129
2021
Q4 		$313K Sell
160
-1,059
-87% -$23.7K 0.05% 125
2021
Q3 		$3.17M Buy
1,219
+313
+35% +$7.38K 0.43% 35
2021
Q2 		$1.99M Sell
906
-404
-31% -$9.92K 0.28% 57
2021
Q1 		$3.06M Buy
1,310
+569
+77% +$17.5K 0.6% 32
2020
Q4 		$1.27M Buy
741
+652
+733% +$10.9K 0.24% 43
2020
Q3 		$145K Buy
+89
New +$1.08K 0.02% 108

Sabby Management's NMTR Position: Q4 2023 in Review

Sabby Management sold out of 9 Meters Biopharma (NMTR) in Q4 2023, closing a stake of 1,672,627 shares — an estimated $20.1K sold.

Sabby Management first reported a position in NMTR in Q2 2019 and held it in 7 quarters. The position peaked at $1.55M in Q2 2019. 1 fund tracked by Wall St. Rank holds NMTR as of Q4 2023.

  • Sabby Management reported no remaining 9 Meters Biopharma position as of Q4 2023 after selling out during the quarter.
  • Sabby Management sold 1,672,627 9 Meters Biopharma shares in Q4 2023, an estimated $20.1K.
  • Sabby Management first reported a position in 9 Meters Biopharma in Q2 2019 and held it in 7 quarters.
  • Sabby Management's 9 Meters Biopharma position peaked at $1.55M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2023.

Based on Sabby Management's 13F filing for Q4 2023, filed 14 Feb 2024.